Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SOLARA ACTIVE PHARMA SCIENCES LTD.

NSE : SOLARABSE : 541540ISIN CODE : INE624Z01016Industry : Pharmaceuticals & DrugsHouse : Private

BSE481.20-7.95 (-1.63 %)

PREV CLOSE ( ) 489.15

OPEN PRICE ( ) 489.25

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 31696

TODAY'S LOW / HIGH ( )476.10 498.55

52 WK LOW / HIGH ( )264.51 559.39

NSE481.70-6.1 (-1.25 %)

PREV CLOSE( ) 487.80

OPEN PRICE ( ) 489.70

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 481.70 (890)

VOLUME 173319

TODAY'S LOW / HIGH( ) 475.55 500.00

52 WK LOW / HIGH ( )263.55 558.8

Quarters

Select year

( in Million)

Particulars

Dec 2023

Sep 2023

Jun 2023

Mar 2023

Audited / UnAudited

UnAudited

Net Sales

2487.3

4252.4

3523.1

3806.2

Total Expenditure

4104.2

3876.1

3331.9

3318.5

PBIDT (Excl OI)

-1616.9

376.3

191.2

487.7

Other Income

4.5

11.8

20.4

46.8

Operating Profit

-1612.4

388.09

211.6

534.5

Interest

253.7

244.4

246.1

219.6

Exceptional Items

-627.7

-52.2

PBDT

-2493.8

91.49

-34.50

314.9

Depreciation

259.6

262.1

259.1

264.5

Profit Before Tax

-2753.4

-170.60

-293.6

50.4

Tax

-102.5

12.8

Provisions and contingencies

Profit After Tax

-2753.4

-170.60

-191.1

37.6

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

-2753.4

-170.60

-191.1

37.6

Minority Interest

-1

-4.4

0.1

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

-2753.4

-171.6

-195.5

37.7

Equity Capital

360

Face Value (IN RS)

Reserves

Calculated EPS

-76.48

-4.76

-5.43

1.04

Calculated EPS (Annualised)

-305.93

-19.06

-21.72

4.18

No of Public Share Holdings

25022463

22608716

21847463

21247463

% of Public Share Holdings

69.51

62.81

60.69

59.03

PBIDTM% (Excl OI)

-65.00

8.84

5.42

12.81

PBIDTM%

-64.82

9.12

6.00

14.04

PBDTM%

-100.26

2.15

-0.97

8.27

PBTM%

-110.69

-4.01

-8.33

1.32

PATM%

-110.69

-4.01

-5.42

0.98

Notes

Risk Disclosures on Derivatives

Quarterly Results

SOLARA ACTIVE PHARMA SCIENCES LTD.